Janssen Paul G H, Gorter Kees J, Stolk Ronald P, Rutten Guy E H M
Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands.
Prim Care Diabetes. 2007 Jun;1(2):69-74. doi: 10.1016/j.pcd.2007.02.001. Epub 2007 Mar 29.
To determine cardiovascular risk of screen detected subjects with type 2 diabetes (T2DM), impaired glucose tolerance (IGT) and impaired fasting glucose (IFG). To examine whether BMI is an effect modifier regarding the relation between level of glucose regulation and cardiovascular risk factors.
From 2002 to 2003, 29,251 persons, aged 50-70 years, participated in a population-based diabetes screening programme. Diagnosis was based on the 1999 WHO criteria. Characteristics were assessed of 285 subjects with T2DM, 175 with IGT and 218 with IFG.
IFG did not resemble IGT and T2DM regarding weight and blood pressure. BMI (kg/m2) was 27.3+/-4.4, 29.5+/-5.7, 30.7+/-5.6 in IFG, IGT, DM, respectively; systolic blood pressure (mmHg) 150+/-25, 161+/-24, 162+/-23; diastolic blood pressure (mmHg) 84+/-12, 89+/-12, 90+/-11. The poorer the glycaemic control, the worse levels of BMI, blood pressure and lipids. When BMI was higher, cardiovascular risk factors were more adverse, especially in subjects with diabetes.
Subjects with IFG had lower blood pressure and weight than subjects with IGT and T2DM suggesting IFG is a condition with less risk to develop cardiovascular diseases. Effect modification by BMI was found.
确定通过筛查发现的2型糖尿病(T2DM)、糖耐量受损(IGT)和空腹血糖受损(IFG)患者的心血管疾病风险。研究体重指数(BMI)是否是血糖调节水平与心血管疾病风险因素之间关系的效应修饰因素。
2002年至2003年,29251名年龄在50至70岁之间的人参加了一项基于人群的糖尿病筛查项目。诊断依据1999年世界卫生组织标准。对285例T2DM患者、175例IGT患者和218例IFG患者进行了特征评估。
IFG在体重和血压方面与IGT和T2DM不同。IFG、IGT、糖尿病患者的BMI(kg/m²)分别为27.3±4.4、29.5±5.7、30.7±5.6;收缩压(mmHg)分别为150±25、161±24、162±23;舒张压(mmHg)分别为84±12、89±12、90±11。血糖控制越差,BMI、血压和血脂水平越差。BMI越高,心血管疾病风险因素越不利,尤其是糖尿病患者。
IFG患者的血压和体重低于IGT和T2DM患者,提示IFG发展为心血管疾病的风险较低。发现了BMI的效应修饰作用。